Showing results (41-50 of 116) with videos related to
Sort By:
Pageof 12
Internal Medicine (Tokyo, Japan)|July 3, 2007
Emerging minimal-change nephrotic syndrome in a patient with chronic mesangial proliferative lupus nephritisNaoko Deji, Toshiro Sugimoto, Masami Kanasaki, et al.Diabetes Care|December 11, 2012
Predictive effects of urinary liver-type fatty acid-binding protein for deteriorating renal function and incidence of cardiovascular disease in type 2 diabetic patients without advanced nephropathyShin-ichi Araki, Masakazu Haneda, Daisuke Koya, et al.Journal of Diabetes Investigation|July 24, 2012
Association between urinary angiotensinogen levels and renal and cardiovascular prognoses in patients with type 2 diabetes mellitusMakoto Sawaguchi, Shin-Ichi Araki, Hiroyuki Kobori, et al.Pharmacology|July 18, 2015
Population Pharmacokinetics and Therapeutic Efficacy of Febuxostat in Patients with Severe Renal ImpairmentDaiki Hira, Yugo Chisaki, Satoshi Noda, et al.Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|November 21, 2013
Glycated albumin predicts the risk of mortality in type 2 diabetic patients on hemodialysis: evaluation of a target level for improving survivalKeiji Isshiki, Toshiki Nishio, Motohide Isono, et al.Modern Rheumatology|October 14, 2006
Scleroderma renal crisis in a patient with anticentromere antibody-positive limited cutaneous systemic sclerosisToshiro Sugimoto, Mariko Soumura, Kiichiro Danno, et al.Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 22, 2009
Target for glycemic control in type 2 diabetic patients on hemodialysis: effects of anemia and erythropoietin injection on hemoglobin A(1c)Takashi Uzu, Tsuguru Hatta, Naoko Deji, et al.Biochemical and Biophysical Research Communications|January 24, 2016
Renoprotective effect of DPP-4 inhibitors against free fatty acid-bound albumin-induced renal proximal tubular cell injuryYuki Tanaka, Shinji Kume, Masami Chin-Kanasaki, et al.Biochemical and Biophysical Research Communications|February 25, 2006
N-acetyl-seryl-aspartyl-lysyl-proline inhibits DNA synthesis in human mesangial cells via up-regulation of cell cycle modulatorsKeizo Kanasaki, Masakazu Haneda, Toshiro Sugimoto, et al.Journal of Diabetes Investigation|November 21, 2014
Oral glucose-stimulated serum C-peptide predicts successful switching from insulin therapy to liraglutide monotherapy in Japanese patients with type 2 diabetes and renal impairmentHisazumi Araki, Yuki Tanaka, Syohei Yoshida, et al.Pageof 12